Objective The effects of exercise training on nocturnal blood pressure (BP) dipping status remain unclear. African Americans have the highest prevalence of nondippers compared with other racial/ethnic populations. In this 6-month study we tested the hypothesis that long-term aerobic exercise training would increase the levels of nocturnal BP dipping in African American nondippers.
Introduction
Blood pressure (BP) has a circadian rhythm in which it decreases at night and increases in the morning. Individuals showing a blunted or absent nocturnal BP reduction, known as nondipping, have been reported to have an increased risk for hypertension, cardiovascular events, and mortality [1] [2] [3] [4] . The clinical and prognostic importance of the absence of a normal reduction in BP at night has been demonstrated by the fact that the nondipper pattern of BP variation is associated with reduced renal function in both normotensive and hypertensive populations [5] [6] [7] . In addition, nocturnal BP has been considered to be a more important risk factor than office BP as it is not affected by the 'white-coat effect' and therefore may be a better method of risk stratification for untreated patients with office hypertension [8] [9] [10] .
A decrease of 10-20% in night-time BP has been considered to be a normal level of dipping. Lack of nocturnal reduction -that is, less than 10% decrease compared with the daytime BP value -has been associated with increased cardiovascular disease (CVD) risk factors [11, 12] .
Race is an independent factor that is related to both hypertension and CVD. It is reported that African Americans have the highest prevalence of hypertension [13, 14] . A growing number of ambulatory BP (ABP) studies have reported that African Americans show less nocturnal reduction in BP than Caucasians [15] [16] [17] [18] . Given that increased CVD risk is associated with nondipping, there is a need for efforts toward restoring the nocturnal decline in BP in African Americans.
Aerobic exercise training (AEXT) is one of the nonpharmacologic approaches recommended for hypertension prevention and treatment, and evidence has shown AEXT has a substantial effect on BP control in African Americans [13] [14] [15] . The effects of lifestyle behavior changes on nocturnal BP, however, are largely unknown. Despite extensive studies demonstrating the health benefits of regular exercise, a relatively low percentage of African Americans participate in routine exercise, which can contribute to hypertension and CVD [16, 17] . Some studies have identified nondippers, compared with dippers, as being nonresponders to exercise with regard to BP management [18, 19] . To our knowledge, however, the effects of AEXT on nocturnal BP in African American nondippers have not been reported. The purpose of the present study was to investigate the effect of chronic aerobic exercise on the BP dipping status in a selected population of African Americans. It was hypothesized that 6 months of supervised AEXT would increase the nocturnal BP dipping levels and thereby reduces CVD risk in African American nondippers.
Methods

Participants
Participants were recruited through mailed brochures and local newspaper advertisements. On response to either, participants were contacted by telephone to assess eligibility. Each participant gave written informed consent following explanation of the study protocol during their first laboratory visit. The protocol was approved by the Temple University Institutional Review Board. The study included African Americans between the ages of 40 and 63 years who were sedentary (regular aerobic exercise < 2 days/week), nonsmoking, not on lipidlowering medication, had a clinic BP less than 160/100 mmHg, and had no history of CVD, diabetes, hypercholesterolemia, renal disease, or lung disease. Both premenopausal and postmenopausal women were included in the study; all postmenopausal women were not on hormone replacement therapy during the study. Participants administering more than one antihypertensive medication were excluded from the study and those using only one antihypertensive medication were tapered off their medication before any testing.
Screening
To ensure the eligibility of all qualified participants, three screening visits were completed before inclusion in the study. Screening visit one included blood sampling and urinalysis following a 12-h overnight fast to assess blood chemistries and renal function. Any individual with total cholesterol greater than 240 mg/dl or fasting blood glucose greater than 126 mg/dl was excluded from the study. Estimated glomerular filtration rate (eGFR) was calculated using the four-variable modification of diet in renal disease study equation specific to African Americans [20] . Any individual who exhibited evidence of renal disease (eGFR ≤ 60 ml/min/1.73 m 2 ) was excluded from the study. Screening visits two and three required all qualified participants to undergo a physician-administered physical examination and echocardiogram bicycle stress test to confirm that they showed no evidence of cardiovascular, pulmonary, or other chronic diseases. In all, 34 African American adults were screened. A total of 18 nondipping participants who were qualified on the basis of ABP, exercise testing, and nocturnal BP patterns participated in the study.
Dietary stabilization
To rule out the confounding effect of variations in dietary intake, participants who met all inclusion criteria after screening underwent dietary stabilization for 6 weeks before testing. Any participant receiving antihypertensive monotherapy (n = 3) was tapered off of their medication during this dietary stabilization period. Participants were instructed by a registered dietician on the American Heart Association Dietary Guidelines for Healthy American Adults [21] . This diet consisted of ∼ 55% of total daily calories from carbohydrates, 15% from proteins, and less than 30% from fat, with saturated fat up to 10% of total calories, sodium up to 3-4 g/day, and cholesterol intake less than 300 mg/day. Participants met with the dietician once per week, at which time body weight was recorded for each visit. Participants were required to remain within 5% of their study entry body weight for the duration of the study to minimize the influences of changes in body weight on blood pressure. Compliance with the prescribed diet was monitored by periodic completion of a 3-day food record throughout the study. All participants remained on this diet until final testing was completed.
Office blood pressure measurements
Office BP measurements were made in accordance with JNC 7 guidelines [22] on three separate visits by trained laboratory personnel. BP was measured using an aneroid sphygmomanometer after 5 min of quiet rest in a chair with feet on the floor and the arm supported at the heart level. The appropriate cuff size was determined on the basis of the upper-arm circumference. BP measurements were performed in triplicate, with 5-min intervals between measurements, and the average of the three values was used as the BP for the visit. The mean duration between visits 1 and 2 was 7 1 days. The mean duration between visits 2 and 3 was 8 1 days. The mean systolic BP (SBP) and diastolic BP (DBP) values from each visit were used across study visits.
24-h ambulatory blood pressure monitoring
Participants underwent 24-h ABP monitoring (ABPM) using a noninvasive monitor (Model 90219; SpaceLabs Medical, Redmond, Washington, USA) beginning on the morning of each participant's typical day, with the exclusion of Friday through Sunday. The BP cuff was fitted to the participant's nondominant arm, with cuff size determined on the basis of the upper-arm circumference. BP measurements were obtained at 30-min intervals during the day (0600-2200 h) and 60-min intervals at night (2200-0600 h). Participants were instructed not to exercise before or during the monitoring period and to pause momentarily and maintain their body position during each BP measurement. Throughout the duration of the recording period, participants were required to maintain a diary in which they recorded their activity and mood at the time of each BP measurement. Only recordings of good technical quality (>80% of valid BP measurements) were included in the final analyses.
Exercise training program
A submaximal graded exercise test was performed to determine the participants' cardiovascular fitness and to develop individualized exercise prescriptions for the AEXT intervention. A modified Bruce protocol submaximal treadmill exercise test was performed with continuous measurement of breath-by-breath gas sampling oxygen consumption (VO 2 ) using a calibrated metabolic cart (Vmax Encore; SensorMedics, Yorba Linda, California, USA). ECG was continuously monitored, and the treadmill test was terminated when the participant reached 75-80% of their predicted heart rate (HR) reserve. A standard regression formula using data collected by indirect calorimetry (VO 2 averaged over each 60-s period) and ECG (minute HRs) was used to predict VO 2max , a measure of cardiovascular fitness, as recommended by the American College of Sports Medicine Guidelines for Exercise Testing and Prescription. Participants then engaged in a 24-week AEXT intervention under direct supervision of lab personnel three times per week, beginning with 20 min of exercise/session at 50% VO 2max . Training duration was then increased by 5 min each week until 40 min of exercise at 50% VO 2max was reached. Thereafter training intensity was increased by 5% each week until 65% VO 2max was achieved. At week 8, participants reached the desired exercise duration and intensity of 40 min at 65% VO 2max , which they maintained as their prescription for the remainder of the study. Exercise modes included treadmill walking/jogging, stair stepping, stationary cycling, rowing ergometry, arm ergometry, and elliptical crosstraining. To monitor exercise intensity, participants were instructed on how to use HR monitors. Study personnel recorded the participants' exercise mode, HR, and duration in printed logs every 10 min to ensure adherence to the prescribed exercise training program. HR was recorded every 10 min. At week 12, participants completed a second submaximal treadmill exercise test as a basis for adjustment of their exercise prescription to account for changes in cardiovascular fitness. The gradual progression of training duration and intensity was used to avoid excessive fatigue and musculoskeletal complaints, thereby maximizing adherence.
Blood sample outcome measures
On the morning after a 12-h overnight fast, blood samples were drawn into EDTA tubes. Samples were centrifuged at 3000 rpm for 20 min at 4°C, after which plasma samples were sent to Quest Diagnostics Inc. (Madison, New Jersey, USA) as per the standard instructions for the measurement of blood glucose, total cholesterol, triglyceride, and highsensitivity C-reactive protein (hs-CRP) levels.
Statistical analysis
Data are expressed as mean SEM. The distribution of all variables was examined using the Shapiro-Wilk test of normality. Analysis of variance was used to compare patient demographics between men and premenopausal and postmenopausal women. Variables that were not normally distributed (total cholesterol and triglycerides) were log transformed for statistical analyses, but true physiological values are reported throughout the paper for ease of interpretation. Pre-AEXT and post-AEXT values were compared using the paired t-test. Simple linear regression was used to calculate relationships between the variables. P-values less than 0.05 were considered statistically significant for all analyses. Statistical analyses were carried out using SPSS version 21.0 (SPSS, Chicago, Illinois, USA).
Results
Participants
This population was predominately middle-aged (52.9 6.0 years), and women made up 94% of the total population. The majority of the population was obese (55.6%); 27.8% were overweight and 16.6% had a normal weight. Of the participants, 22.2% were using one antihypertensive medication for BP control before enrollment in the study. One-third of the participants were diagnosed as having prediabetes and the remainder had normal plasma glucose levels. Demographics of the participants are summarized in Table 1 .
Effects of aerobic exercise testing
The effects of AEXT on clinical characteristics are presented in Table 1 . There was a significant increase in predicted VO 2max following AEXT. The AEXT intervention also elicited a significant increase in eGFR. Fasting glucose and circulating levels of hs-CRP showed significant decreases following AEXT. There were no significant changes in total cholesterol and triglyceride levels, or BMI.
Aerobic exercise testing did not change 24-h average blood pressure
As shown in Table 2 , 6 months of AEXT did not result in significant changes in office SBPs or DBPs. There were also no significant changes in the 24-h average daytime and night-time SBPs and DBPs before and after 6 months of AEXT.
Aerobic exercise testing increased blood pressure dipping levels and changed the nondipping pattern The 6-month AEXT intervention elicited significant increases in dipping levels of SBP (Fig. 1a, the 18 (44.4%) participants changed from an SBP nondipper to an SBP dipper pattern. One-third of the participants remained nondippers but showed increases in their levels of dipping. Although the differences were not statistically significant with regard to dipping levels of DBP (Fig. 1a , baseline: 11.2 8.2% vs. final: 14.0 5.3%), greater dipping levels of DBP were observed after 6 months of AEXT. At final testing, the number of DBP nondippers decreased from four (44.4%) to two (22.2%). Figure 2 summarizes the average hourly SBP dipping levels for the study group at both baseline and final measurements at night-time.
Dipping statuses of HR, mean arterial pressure (MAP), and pulse pressure (PP) were also examined both at baseline and following AEXT ( Table 2) . No significant differences were found in HR or MAP between the baseline and final measurements. After 6 months of AEXT, dipping status of PP increased significantly, suggesting that this risk factor for CVD was lowered.
Discussion
In this study, we selected a group of 18 African American participants with nondipping status to complete a 6-month AEXT intervention. The current findings are the first, to our knowledge, to show that AEXT improves the levels of BP dipping in this high-risk population of African Americans with nondipping status. In particular, we found that AEXT significantly increased the Values are reported as mean SD. Daytime: 6:00 a.m. to 10:00 p.m.; night-time: 10:00 p.m. to 6:00 a.m. DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure. nocturnal reduction in SBP and PP. Moreover, ∼ 44% of the individuals who were classified as nondippers at study entry were classified as dippers following AEXT.
AEXT was chosen for this study because it is considered to be effective in controlling BP in participants with hypertension or at high risk for hypertension [23] . Further, the understanding of chronic aerobic exercise adaptations allows for more efficacious study into possible variations of exercise prescriptions for nonresponsive groups such as nondippers.
The effect of AEXT on ABP has not been fully determined, especially in high-risk populations such as African Americans and nondippers. Several studies have reported inconsistent results on the effects of exercise on the BP dipping status [24] [25] [26] . In the present study, at baseline, participants had blunted nocturnal reduction of BP, as demonstrated by an average level of dipping of 5.8 3.9%. After 6 months of AEXT, the results showed a beneficial effect of chronic exercise on nocturnal BP dipping through an increase in the level to 9.4 6.0%. The results provide further evidence that increased daytime physical activity is a factor that contributes toward greater nocturnal BP dipping [12, 27] .
There was no significant change in the 24-h average HR or MAP after 6 months of AEXT. According to a previous study, blunted HR dipping independently predicts cardiovascular mortality [28] . HR is less dependent than BP on physical activity and is therefore less confounded by daily activities involving exercise or movement [29, 30] . This may explain why there was no significant change in 24-h HR after chronic AEXT. In addition, MAP is determined by the product of cardiac output and systemic vascular resistance, which was found to be strongly associated with younger but not older participants [31] . The average age of the present study group is 52.9 6.0 years, and this might be a reason for the unchanged MAP after chronic AEXT.
In the present study, no changes were observed in office or 24-h average ABP or office BP after 6 months of AEXT. This finding is consistent with those of previous studies that showed that AEXT sometimes failed to reduce 24-h average ABP in nondipping hypertensive individuals [18, 19] . We wanted to determine whether the lack of change in the 24-h average ABP or office BP was due to our modest sample size. Therefore, we retrospectively calculated the effect sizes for the differences between baseline and final office BPs. On the basis of these effect sizes, to observe a significant difference between baseline and final office SBPs, the sample size needed to be 433. For the difference in office DBPs, the sample size needed to be 292. Thus, we are confident that the lack of change in BP was not due to the small sample size.
The AEXT intervention improved many of the abnormalities associated with greater cardiovascular risk: reduced eGFR, elevated hs-CRP levels, and high blood glucose levels. Given the increased cardiovascular risk in African Americans, an intervention that has the potential to improve abnormalities associated with cardiovascular risk is promising, particularly among older individuals with elevated BP who are more likely to have hypertension and CVD.
The Ohasama study examined 1542 participants from a general population, aged 40 years or older, and found that each 5% decrease in nocturnal BP dipping was associated with an 18% increase in the risk for cardiovascular mortality [12] . In the present study, no significant correlations were found between the increase in nocturnal BP dipping and the changes in body weight, eGFR, hs-CRP level, serum total cholesterol level, and triglyceride level after 6 months of AEXT. The results of the present study show that the improvement in BP dipping status elicited by AEXT is independent of these changes, which is in agreement with an earlier study that reported that increased physical activity levels were independent predictors of the magnitude of nocturnal dip in BP [32] . This suggests that the increased dipping level elicited by AEXT may be beneficial as an adjunct to cardiovascular health in this population.
There are some limitations to the present study. First, there was no nondipper control group for the exercise training. As the participants we recruited were individuals with higher cardiovascular risk factors, and some of them used antihypertensive medications, we could not taper the medication without adding any interventions. Second, the relatively small sample size is also a limiting factor. The study population included sedentary and apparently healthy African Americans without diabetes and with clinical BP less than 160/100 mmHg, who were able to complete 6 months of AEXT, therefore making this a highly selective population. Third, the reproducibility of ABPM is controversial because of the large influence of daily activity on BP [33, 34] . However, there are several studies that have shown highly reproducible results of both short-term and long-term ABPM recordings [6, 35] . Still, further repetition of the ABPM sessions over a longer period of time may have provided an even more accurate BP profile of the participants.
Conclusion
Long-term AEXT proved effective among African Americans with nondipping status, resulting in improved nocturnal reduction in SBP and PP. More research is needed to determine the optimal intensity of aerobic training that results in reductions in 24-h BP, as well as in nocturnal reductions in BP. Given the high prevalence of nondipping among African Americans, AEXT may be useful as a treatment modality in the management of BP levels among African Americans.
